Ang Li

5.1k citations
61 papers · 2.0k indexed · 1 hit paper · h-index 18
Topics
Pancreatic and Hepatic Oncology Research (21 papers)Cancer Immunotherapy and Biomarkers (17 papers)Cancer Genomics and Diagnostics (9 papers)
Partner nations
ChinaUnited StatesSpain

In The Last Decade

Ang Li

57 papers receiving 2.0k citations

Hit Papers

Five-Year Follow-Up of Nivolumab in Previously Treated Ad...20182026202020232018100200300400500

Peers

Ang Li
Comparison fields: 5 of 104
  • Oncology 1.5k
  • Molecular Biology 652
  • Pulmonary and Respiratory Medicine 619
  • Cancer Research 405
  • Surgery 335
Replace Michael Pins with:
Michael Pins United States
Yoichi Naito Japan
Virote Sriuranpong Thailand
Carmen Belli Italy
Pol Specenier Belgium
Hiroyuki Yamaguchi Japan
Holger W. Hirte Canada
Alexander J. Chou United States
Stephan Krüger Germany
Hitoshi Kusaba Japan
Ang Li relative to Michael Pins United States Michael Pins's profile →
Citations per field
00.5×11.1×
Michael Pins · 1×
Citations per year

Countries citing papers authored by Ang Li

Since Specialization
Citations

This map shows the geographic impact of Ang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ang Li more than expected).

Fields of papers citing papers by Ang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ang Li. The network helps show where Ang Li may publish in the future.

Co-authorship network of co-authors of Ang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ang Li. A scholar is included among the top collaborators of Ang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ang Li. Ang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 14
3 11
4 15
5 2
6 0
7 11
8 1
9 17
10 70
11 3
12 2
13 30
14 13
15 10
16 2
17 57
18 174
19 48
20 63

About Ang Li

Ang Li is a scholar working on Oncology, Immunology and Allergy and Cancer Research, having authored 61 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (21 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (405 citations) and Pulmonary and Respiratory Medicine (619 citations). Ang Li has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Michael Goggins, Ralph H. Hruban, Julie R. Brahmer, Seung‐Mo Hong, Scott Antonia, Leora Horn, Scott Gettinger, Matthew D. Hellmann, David R. Spigel and William J. Geese. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026